UNICREDIT BANK/CALL/NOVO-NORDISK B/900/0.1/18.09.24 Share Price

Warrant

DE000HC9M402

Market Closed - BOERSE MUENCHEN 01:16:09 29/06/2024 am IST
1.7 EUR -1.16% Intraday chart for UNICREDIT BANK/CALL/NOVO-NORDISK B/900/0.1/18.09.24
Current month+68.32%
1 month+73.47%
Date Price Change
28/24/28 1.7 -1.16%
27/24/27 1.72 -0.58%
26/24/26 1.73 -10.82%
25/24/25 1.94 +25.97%
24/24/24 1.54 -2.53%

Real-time BOERSE MUENCHEN

Last update June 29, 2024 at 01:16 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer UniCredit UniCredit
WKN HC9M40
ISINDE000HC9M402
Date issued 02/10/2023
Strike 900 kr
Maturity 18/09/2024 (80 Days)
Parity 10 : 1
Emission price 0.37
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.97
Lowest since issue 0.29
Delta0x
Omega 0.000000
Premium0x
Gearing8.02x
Moneyness 1.117
Difference Strike -105.6 kr
Difference Strike %-11.73%
Spread 0.04
Spread %2.35%
Intrinsic value 1.415
Present value 0.2604

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006 DKK
Average target price
949.7 DKK
Spread / Average Target
-5.56%
Consensus